Positive allosteric modulators of the α7 nicotinic acetylcholine receptor and uses thereof
US9062013B2 · kind B2 · utility
3Cited by
1References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 2, 2012 |
| Grant date | Jun 23, 2015 |
| Priority date | — |
| Expiry date | Feb 2, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds useful in the positive modulation of the alpha 7 nicotinic acetylcholine receptor (α7nAChR). The invention also relates to the use of these compounds in the treatment or prevention of a broad range of diseases in which the positive modulation of α7nAChR is advantageous, including neurodegenerative and neuropsychiatric diseases and also inflammatory diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.